| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-19 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |